One-year access to more than 500 world journals available in the system
-
http://medilib.ir
- Duration of Time : 365 Day
Price : 300$- Special Price : 100$
Journals package 3months
-
http://medilib.ir
- Duration of Time : 93 Day
- :
Price : 100$- Special Price : 50$
Polycystic Kidney Disease: A Disorder Out of Time?.
doi : 10.1681/ASN.0000000617
Volume 36(3) pgs. 331-532 March 2025
Glomerular Hyperfiltration and Tubuloglomerular Feedback in Diabetic Kidney Disease: Physiological Insights and Potential Clinical Translation.
doi : 10.1681/ASN.0000000615
Why Is C5a Inflammatory Complement Inhibition Not Enough to Improve C3 Glomerulopathy?.
doi : 10.1681/ASN.0000000631
Role of Z-DNA Binding Protein 1 Sensing Mitochondrial Z-DNA and Triggering Necroptosis in Oxalate-Induced Acute Kidney Injury.
doi : 10.1681/ASN.0000000516
Circadian Clock Disruption and Growth of Kidney Cysts in Autosomal Dominant Polycystic Kidney Disease.
doi : 10.1681/ASN.0000000528
Piezo, Nephrocyte Function, and Slit Diaphragm Maintenance in Drosophila.
doi : 10.1681/ASN.0000000529
Autoantibodies Targeting Proteasome Subunit Alpha Type 1 in Autoimmune Podocytopathies.
doi : 10.1681/ASN.0000000525
Transmembrane Serine Protease 2 and Proteolytic Activation of the Epithelial Sodium Channel in Mouse Kidney.
doi : 10.1681/ASN.0000000521
Advancing Community Care and Access to Follow-Up after Acute Kidney Injury Hospitalization: A Randomized Clinical Trial.
doi : 10.1681/ASN.0000000537
Urinary Cytokeratin 20 as a Biomarker for AKI-CKD Transition among Patients with Acute Decompensated Heart Failure and Acute Kidney Injury.
doi : 10.1681/ASN.0000000518
Acetazolamide Therapy and Kidney Function in Persons with Nonalbuminuric Diabetes Mellitus Type 1.
doi : 10.1681/ASN.0000000515
Self-Supervised Learning for Feature Extraction from Glomerular Images and Disease Classification with Minimal Annotations.
doi : 10.1681/ASN.0000000514
Safety and Efficacy of Avacopan in Patients with Complement 3 Glomerulopathy: Randomized, Double-Blind Clinical Trial.
doi : 10.1681/ASN.0000000526
Nanotherapeutics in Kidney Disease: Innovations, Challenges, and Future Directions.
doi : 10.1681/ASN.0000000608
Simulation-Based Sample Size Estimation in Clinical Trials in Nephrology.
doi : 10.1681/ASN.0000000560
Prevalence and Impact of APOL1 Kidney Risk Variants in West Africa: Insights for Global Kidney Disease Assessment and Treatment.
doi : 10.1681/ASN.0000000587
